Nature has provided many drugs capable of treating and alleviating human diseases.
Terrestrial plants, bacteria, insects, fungi, and bee products have played major roles in …

Despite decades of study, the molecular mechanisms and selectivity of the biomolecular
components of honeybee (Apis mellifera) venom as anticancer agents remain largely …

Given the vast number of venomous and poisonous animals, it is surprising that only
relatively few animal-derived toxins have been explored and made their way into marketed …

Bee venom (BV) is a toxin produced naturally by honey bees with several toxic and
therapeutic efficacies. It is used in the treatment of different cancer kinds like renal, hepatic …

Background Apitherapy is an emerging field in cancer research, particularly in developing
communities. The potency of Melittin (MEL), a major constituent in bee venom is accounted …

Objective: Breast cancer is the most common case of cancers. Apitheraphy has been
traditionally used for abundance diseases. This study aims to evaluate and compare the anti …

Apitoxin, also known as bee venom (BV), is produced in two specialized abdominal glands
of worker bees and is used as a defence weapon of bees' colony (Choi et al., 2015; Zhang et …

Extraction and characterization of natural products provide the opportunity to expand our
arsenal of drug candidates against a wide range of diseases including cancer and …

Glioblastoma multiforme (GBM) is a frequent form of malignant glioma. Strategic therapeutic
approaches to treat this type of brain tumor currently involves a combination of surgery …

Venoms are complex mixtures of different molecules and ions. Among them, bioactive
peptides have been found to affect cancer hallmarks, such as cell proliferation, cell invasion …